Penfund invests in OMERS’ acquisition of Gastro Health

Penfund led a US$90 million second lien credit facility and invested US$10 million of equity in Gastro Health, a Miami-based gastroenterology company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this